(RTTNews) - Astellas Pharma Inc. (ALPMY) Wednesday announced the submission of a New Drug Application or NDA in Japan for Conditional Approval of Avacincaptad Pegol intravitreal solution or ACP for ...
InMed Pharmaceuticals Inc. (NASDAQ: INM) revealed its decision regarding the selection of an intravitreal (IVT) formulation for INM-089 as a drug candidate. This choice is part of the company’s ...